IBDEI1H3 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25006,1,3,0)
 ;;=3^Adjustment Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,25006,1,4,0)
 ;;=4^F43.20
 ;;^UTILITY(U,$J,358.3,25006,2)
 ;;=^5003573
 ;;^UTILITY(U,$J,358.3,25007,0)
 ;;=F43.9^^93^1125^16
 ;;^UTILITY(U,$J,358.3,25007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25007,1,3,0)
 ;;=3^Trauma/Stressor-Related Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,25007,1,4,0)
 ;;=4^F43.9
 ;;^UTILITY(U,$J,358.3,25007,2)
 ;;=^5003576
 ;;^UTILITY(U,$J,358.3,25008,0)
 ;;=F43.11^^93^1125^9
 ;;^UTILITY(U,$J,358.3,25008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25008,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,25008,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,25008,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,25009,0)
 ;;=F43.12^^93^1125^10
 ;;^UTILITY(U,$J,358.3,25009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25009,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,25009,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,25009,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,25010,0)
 ;;=F43.10^^93^1125^11
 ;;^UTILITY(U,$J,358.3,25010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25010,1,3,0)
 ;;=3^PTSD,Unspec
 ;;^UTILITY(U,$J,358.3,25010,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,25010,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,25011,0)
 ;;=F43.8^^93^1125^12
 ;;^UTILITY(U,$J,358.3,25011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25011,1,3,0)
 ;;=3^Reaction to Severe Stress,Other
 ;;^UTILITY(U,$J,358.3,25011,1,4,0)
 ;;=4^F43.8
 ;;^UTILITY(U,$J,358.3,25011,2)
 ;;=^5003575
 ;;^UTILITY(U,$J,358.3,25012,0)
 ;;=F43.9^^93^1125^13
 ;;^UTILITY(U,$J,358.3,25012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25012,1,3,0)
 ;;=3^Reaction to Severe Stress,Unspec
 ;;^UTILITY(U,$J,358.3,25012,1,4,0)
 ;;=4^F43.9
 ;;^UTILITY(U,$J,358.3,25012,2)
 ;;=^5003576
 ;;^UTILITY(U,$J,358.3,25013,0)
 ;;=F94.1^^93^1125^14
 ;;^UTILITY(U,$J,358.3,25013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25013,1,3,0)
 ;;=3^Reactive Attachment Disorder
 ;;^UTILITY(U,$J,358.3,25013,1,4,0)
 ;;=4^F94.1
 ;;^UTILITY(U,$J,358.3,25013,2)
 ;;=^5003705
 ;;^UTILITY(U,$J,358.3,25014,0)
 ;;=F94.2^^93^1125^8
 ;;^UTILITY(U,$J,358.3,25014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25014,1,3,0)
 ;;=3^Disinhibited Social Engagement Disorder
 ;;^UTILITY(U,$J,358.3,25014,1,4,0)
 ;;=4^F94.2
 ;;^UTILITY(U,$J,358.3,25014,2)
 ;;=^5003706
 ;;^UTILITY(U,$J,358.3,25015,0)
 ;;=F18.10^^93^1126^21
 ;;^UTILITY(U,$J,358.3,25015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25015,1,3,0)
 ;;=3^Inhalant Use Disorder,Mild
 ;;^UTILITY(U,$J,358.3,25015,1,4,0)
 ;;=4^F18.10
 ;;^UTILITY(U,$J,358.3,25015,2)
 ;;=^5003380
 ;;^UTILITY(U,$J,358.3,25016,0)
 ;;=F18.20^^93^1126^22
 ;;^UTILITY(U,$J,358.3,25016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25016,1,3,0)
 ;;=3^Inhalant Use Disorder,Moderate-Severe
 ;;^UTILITY(U,$J,358.3,25016,1,4,0)
 ;;=4^F18.20
 ;;^UTILITY(U,$J,358.3,25016,2)
 ;;=^5003392
 ;;^UTILITY(U,$J,358.3,25017,0)
 ;;=F18.21^^93^1126^23
 ;;^UTILITY(U,$J,358.3,25017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25017,1,3,0)
 ;;=3^Inhalant Use Disorder,Moderate-Severe,In Remission
 ;;^UTILITY(U,$J,358.3,25017,1,4,0)
 ;;=4^F18.21
 ;;^UTILITY(U,$J,358.3,25017,2)
 ;;=^5003393
 ;;^UTILITY(U,$J,358.3,25018,0)
 ;;=F18.14^^93^1126^24
 ;;^UTILITY(U,$J,358.3,25018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25018,1,3,0)
 ;;=3^Inhalant-Induced Depressive Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25018,1,4,0)
 ;;=4^F18.14
 ;;^UTILITY(U,$J,358.3,25018,2)
 ;;=^5003384
 ;;^UTILITY(U,$J,358.3,25019,0)
 ;;=F18.24^^93^1126^25
 ;;^UTILITY(U,$J,358.3,25019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25019,1,3,0)
 ;;=3^Inhalant-Induced Depressive Disorder w/ Moderate to Severe Use Disorder
